Delivery Order SPE2DB20D6035-SPE2DB24FD2QB

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $2,553.24 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the medication Ferumoxytol 510 mg/17 ml vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The delivery order, valued at $1,675.80, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,793.00, is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a $1,439.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of FERUMOXYTOL 510 MG/17 ML VIAL 17ML medical supplies, with an ultimate completion date of April 4, 2025. This delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 17 mL vials of the injectable iron replacement medication ferumoxytol. The $13,498 firm fixed price contract has a period of performance through September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and other healthcare providers. The...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,600.04, is for the delivery of ferumoxytol, a 510 mg/17 mL injectable medication, and is classified as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen is a for-profit organization registered in the...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA). The $4,011.53 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2022, with an ultimate completion date of August 11, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
  • SPE2DB20D6035
    Indefinite Delivery Contract
  • SPE2DB20D6035-SPE2DB24FD2QB
    Delivery Order

The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,619.76, is for the supply of 17 ml vials of the pharmaceutical drug Ferumoxytol. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 1, 2024.

Generated 10/30/24, 9:56 AM